Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' SCHOEPP DD' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 104 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Marek, GJ; Wright, RA; Gewirtz, JC; Schoepp, DD
      A major role for thalamocortical afferents in serotonergic hallucinogen receptor function in the rat neocortex

      NEUROSCIENCE
    2. Cartmell, J; Perry, KW; Salhoff, CR; Monn, JA; Schoepp, DD
      Acute increases in monoamine release in the rat prefrontal cortex by the mGlu2/3 agonist LY379268 are similar in profile to risperidone, not locally mediated, and can be elicited in the presence of uptake blockade

      NEUROPHARMACOLOGY
    3. Thomas, NK; Wright, RA; Howson, PA; Kingston, AE; Schoepp, DD; Jane, DE
      (S)-3,4-DCPG, a potent and selective mGlu8a receptor agonist, activates metabotropic glutamate receptors on primary afferent terminals in the neonatal rat spinal cord

      NEUROPHARMACOLOGY
    4. Schoepp, DD
      Unveiling the functions of presynaptic metabotropic glutamate receptors inthe central nervous system

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    5. Wright, RA; Arnold, MB; Wheeler, WJ; Ornstein, PL; Schoepp, DD
      [H-3]LY341495 binding to group II metabotropic glutamate receptors in rat brain

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    6. Chen, Y; Bacon, G; Sher, E; Clark, BP; Kallman, MJ; Wright, RA; Johnson, BG; Schoepp, DD; Kingston, AE
      Evaluation of the activity of a novel metabotropic glutamate receptor antagonist (+/-)-2-amino-2-(3-cis and trans-carboxycyclobutyl-3-(9-thioxanthyl acid) in the in vitro neonatal spinal cord and in an in vivo pain model

      NEUROSCIENCE
    7. Monn, JA; Schoepp, DD
      Metabotropic glutamate receptor modulators: Recent advances and therapeutic potential

      ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 35
    8. Wright, RA; Arnold, MB; Wheeler, WJ; Ornstein, PL; Schoepp, DD
      Binding of [H-3] (2S,1 ' S,2 ' S)-2-(9-xanthylmethyl)-2-(2 '-carboxycycloprophyl) glycine ([H-3]LY341495) to cell membranes expressing recombinant human group III metabotropic glutamate receptor subtypes

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    9. Cartmell, J; Monn, JA; Schoepp, DD
      Tolerance to the motor impairment, but not to the reversal of PCP-induced motor activities by oral administration of the mGlu2/3 receptor agonist, LY379268

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    10. Bond, A; Jones, NM; Hicks, CA; Whiffin, GM; Ward, MA; O'Neill, MF; Kingston, AE; Monn, JA; Ornstein, PL; Schoepp, DD; Lodge, D; O'Neill, MJ
      Neuroprotective effects of LY379268, a selective mGlu2/3 receptor agonist:Investigations into possible mechanism of action in vivo

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    11. Marek, GJ; Wright, RA; Schoepp, DD; Monn, JA; Aghajanian, GK
      Physiological antagonism between 5-hydroxytryptamine(2A) and group II metabotropic glutamate receptors in prefrontal cortex

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    12. Cartmell, J; Schoepp, DD
      Regulation of neurotransmitter release by metabotropic glutamate receptors

      JOURNAL OF NEUROCHEMISTRY
    13. Cartmell, J; Perry, KW; Salhoff, CR; Monn, JA; Schoepp, DD
      The potent, selective mGlu2/3 receptor agonist LY379268 increases extracellular levels of dopamine, 3,4-dihydroxyphenylacetic acid, homovanillic acid, and 5-hydroxyindole-3-acetic acid in the medial prefrontal cortex of the freely moving rat

      JOURNAL OF NEUROCHEMISTRY
    14. Cartmell, J; Monn, JA; Schoepp, DD
      The mGlu(2/3) receptor agonist LY379268 selectively blocks amphetamine ambulations and rearing

      EUROPEAN JOURNAL OF PHARMACOLOGY
    15. Doherty, AJ; Palmer, MJ; Bortolotto, ZA; Hargreaves, A; Kingston, AE; Ornstein, PL; Schoepp, DD; Lodge, D; Collingridge, GL
      A novel, competitive mGlu(5) receptor antagonist (LY344545) blocks DHPG-induced potentiation of NMDA responses but not the induction of LTP in rat hippocampal slices

      BRITISH JOURNAL OF PHARMACOLOGY
    16. Cartmell, J; Salhoff, CR; Perry, KW; Monn, JA; Schoepp, DD
      Dopamine and 5-HT turnover are increased by the mGlu2/3 receptor agonist LY379268 in rat medial prefrontal cortex, nucleus accumbens and striatum

      BRAIN RESEARCH
    17. Cartmell, J; Monn, JA; Schoepp, DD
      Attenuation of specific PCP-evoked behaviors by the potent mGlu2/3 receptor agonist, LY379268 and comparison with the atypical antipsychotic, clozapine

      PSYCHOPHARMACOLOGY
    18. Lam, AGM; Monn, JA; Schoepp, DD; Lodge, D; McCulloch, J
      Group II selective metabotropic glutamate receptor agonists and local cerebral glucose use in the rat

      JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
    19. Schoepp, DD; Jane, DE; Monn, JA
      Pharmacological agents acting at subtypes of metabotropic glutamate receptors

      NEUROPHARMACOLOGY
    20. Johnson, BG; Wright, RA; Arnold, MB; Wheeler, WJ; Ornstein, PL; Schoepp, DD
      [H-3]-LY341495 as a novel antagonist radioligand for group II metabotropicglutamate (mGlu) receptors: characterization of binding to membranes of mGlu receptor subtype expressing cells

      NEUROPHARMACOLOGY
    21. Cartmell, J; Monn, JA; Schoepp, DD
      The metabotropic glutamate 2/3 receptor agonists LY354740 and LY379268 selectively attenuate phencyclidine versus d-amphetamine motor behaviors in rats

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    22. Monn, JA; Valli, MJ; Massey, SM; Hansen, MM; Kress, TJ; Wepsiec, JP; Harkness, AR; Grutsch, JL; Wright, RA; Johnson, BG; Andis, SL; Kingston, A; Tomlinson, R; Lewis, R; Griffey, KR; Tizzano, JP; Schoepp, DD
      Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740): Identification of two new potent, selective, and systemically active agonists for group II metabotropic glutamate receptors

      JOURNAL OF MEDICINAL CHEMISTRY
    23. Kingston, AE; O'Neill, MJ; Lam, A; Bales, KR; Monn, JA; Schoepp, DD
      Neuroprotection by metabotropic glutamate receptor agonists: LY354740, LY379268 and LY389795

      EUROPEAN JOURNAL OF PHARMACOLOGY
    24. ESCRIBANO A; EZQUERRA J; PEDREGAL C; RUBIO A; YRURETAGOYENA B; BAKER SR; WRIGHT RA; JOHNSON BG; SCHOEPP DD
      (2S,4S)-2-AMINO-4-(2,2-DIPHENYLETHYL) PENTANEDIOIC ACID SELECTIVE GROUP 2 METABOTROPIC GLUTAMATE-RECEPTOR ANTAGONIST

      Bioorganic & medicinal chemistry letters
    25. ORNSTEIN PL; ARNOLD MB; LUNN WHW; HEINZ LJ; LEANDER JD; LODGE D; SCHOEPP DD
      HETEROATOM-SUBSTITUTION AS A STRATEGY FOR INCREASING THE POTENCY OF COMPETITIVE NMDA ANTAGONISTS

      Bioorganic & medicinal chemistry letters
    26. COLLADO I; EZQUERRA J; MAZON A; PEDREGAL C; YRURETAGOYENA B; KINGSTON AE; TOMLINSON R; WRIGHT RA; JOHNSON BG; SCHOEPP DD
      3'-DISUBSTITUTED-2-(2'-CARBOXYCYCLOPROPYL)GLYCINES AS POTENT AND SELECTIVE ANTAGONISTS OF METABOTROPIC GLUTAMATE RECEPTORS

      Bioorganic & medicinal chemistry letters
    27. VALLI MJ; SCHOEPP DD; WRIGHT RA; JOHNSON BG; KINGSTON AE; TOMLINSON R; MONN JA
      SYNTHESIS AND METABOTROPIC GLUTAMATE-RECEPTOR ANTAGONIST ACTIVITY OF N-1-SUBSTITUTED ANALOGS OF 2R,4R-4-AMINOPYRROLIDINE-2,4-DICARBOXYLIC ACID

      Bioorganic & medicinal chemistry letters
    28. ORNSTEIN PL; ARNOLD MB; BLEISCH TJ; WRIGHT RA; WHEELER WJ; SCHOEPP DD
      [H-3]LY341495, A HIGHLY POTENT, SELECTIVE AND NOVEL RADIOLIGAND FOR LABELING GROUP-II METABOTROPIC GLUTAMATE RECEPTORS

      Bioorganic & medicinal chemistry letters
    29. FITZJOHN SM; ORNSTEIN PL; SCHOEPP DD; KINGSTON AE; LODGE D; COLLINGRIDGE GL
      ACTIONS OF THE POTENT MGLU RECEPTOR ANTAGONIST LY341495 ON HIPPOCAMPAL LTD AND DEPOTENTIATION

      European journal of neuroscience
    30. BERTOLOTTO ZA; ORNSTEIN PL; SCHOEPP DD; KINGSTON AE; LODGE D; COLLINGRIDGE GL
      ACTIONS OF LY341495, A POTENT MGLU RECEPTOR ANTAGONIST, ON HIPPOCAMPAL LTP

      European journal of neuroscience
    31. LAM AGM; SORIANO MA; MONN JA; SCHOEPP DD; LODGE D; MCCULLOCH J
      EFFECTS OF THE SELECTIVE METABOTROPIC GLUTAMATE AGONIST LY354740 IN ARAT MODEL OF PERMANENT ISCHEMIA

      Neuroscience letters
    32. WU S; WRIGHT RA; ROCKEY PK; BURGETT SG; ARNOLD JS; ROSTECK PR; JOHNSON BG; SCHOEPP DD; BELAGAJE RM
      GROUP-III HUMAN METABOTROPIC GLUTAMATE RECEPTOR-4, RECEPTOR-7 AND RECEPTOR-8 - MOLECULAR-CLONING, FUNCTIONAL EXPRESSION, AND COMPARISON OF PHARMACOLOGICAL PROPERTIES IN RGT CELLS

      Molecular brain research
    33. KINGSTON AE; ORNSTEIN PL; WRIGHT RA; JOHNSON BG; MAYNE NG; BURNETT JP; BELAGAJE R; WU S; SCHOEPP DD
      LY341495 IS A NANOMOLAR POTENT AND SELECTIVE ANTAGONIST OF GROUP-II METABOTROPIC GLUTAMATE RECEPTORS

      Neuropharmacology
    34. Fitzjohn, SM; Bortolotto, ZA; Palmer, MJ; Doherty, MJ; Doherty, AJ; Ornstein, PL; Schoepp, DD; Kingston, AE; Lodge, D; Collingridge, GL
      The potent mGlu receptor antagonist LY341495 identifies roles for both cloned and novel mGlu receptors in hippocampal synaptic plasticity

      NEUROPHARMACOLOGY
    35. SCHOEPP DD; JOHNSON BG; WRIGHT RA; SALHOFF CR; MONN JA
      POTENT, STEREOSELECTIVE, AND BRAIN REGION SELECTIVE MODULATION OF 2NDMESSENGERS IN THE RAT-BRAIN BY (-II METABOTROPIC GLUTAMATE-RECEPTOR AGONIST()LY354740, A NOVEL GROUP)

      Naunyn-Schmiedeberg's archives of pharmacology
    36. SCHOEPP DD; WRIGHT RA; JOHNSON BG; SALHOFF CR; MAYNE NG; BURNETT JP; WU S; MONN JA; ORNSTEIN PL
      CURRENT PHARMACOLOGY OF METABOTROPIC GLUTAMATE-RECEPTOR SUBTYPES

      Naunyn-Schmiedeberg's archives of pharmacology
    37. HELTON DR; TIZZANO JP; MONN JA; SCHOEPP DD; KALLMAN MJ
      ANXIOLYTIC AND SIDE-EFFECT PROFILE OF LY354740 - A POTENT, HIGHLY SELECTIVE, ORALLY-ACTIVE AGONIST FOR GROUP-II METABOTROPIC GLUTAMATE RECEPTORS

      The Journal of pharmacology and experimental therapeutics
    38. KINGSTON AE; BAKER SR; CLARK BP; LODGE D; MONN JA; ONEILL MJ; TIZZANO J; SCHOEPP DD
      NOVEL LIGANDS FOR METABOTROPIC RECEPTORS

      Journal of neurochemistry
    39. ORNSTEIN PL; BLEISCH TJ; ARNOLD MB; WRIGHT RA; JOHNSON BG; SCHOEPP DD
      2-SUBSTITUTED MINO-2-((1SR,2SR)-2-CARBOXYCYCLOPROP-1-YL)GLYCINES AS POTENT AND SELECTIVE ANTAGONISTS OF GROUP-II METABOTROPIC GLUTAMATE RECEPTORS - 1 - EFFECTS OF ALKYL, ARYLALKYL, AND DIARYLALKYL SUBSTITUTION

      Journal of medicinal chemistry
    40. ORNSTEIN PL; BLEISCH TJ; ARNOLD MB; KENNEDY JH; WRIGHT RA; JOHNSON BG; TIZZANO JP; HELTON DR; KALLMAN MJ; SCHOEPP DD; HERIN M
      2-SUBSTITUTED MINO-2-((1SR,2SR)-2-CARBOXYCYCLOPROP-1-YL)GLYCINES AS POTENT AND SELECTIVE ANTAGONISTS OF GROUP-II METABOTROPIC GLUTAMATE RECEPTORS - 2 - EFFECTS OF AROMATIC-SUBSTITUTION, PHARMACOLOGICAL CHARACTERIZATION, AND BIOAVAILABILITY

      Journal of medicinal chemistry
    41. LAM AGM; LODGE D; MONN JA; SCHOEPP DD; MCCULLOCH J
      THE EFFECTS OF THE SELECTIVE GROUP-II METABOTROPIC GLUTAMATE-RECEPTORAGONIST LY354740 ON LOCAL CEREBRAL GLUCOSE-METABOLISM IN THE RAT-BRAIN

      British Journal of Pharmacology
    42. SANG CN; HOSTETTER MP; GRACELY RH; CHAPPELL AS; SCHOEPP DD; LEE G; WHITCUP S; CARUSO R; MAX MB
      AMPA KAINATE ANTAGONIST LY293558 REDUCES CAPSAICIN-EVOKED HYPERALGESIA BUT NOT PAIN IN NORMAL SKIN IN HUMANS/

      Anesthesiology
    43. BLEISCH TJ; ORNSTEIN PL; ALLEN NK; WRIGHT RA; LODGE D; SCHOEPP DD
      STRUCTURE-ACTIVITY STUDIES OF ARYL-SPACED DECAHYDROISOQUINOLINE-3-CARBOXYLIC ACID AMPA RECEPTOR ANTAGONISTS

      Bioorganic & medicinal chemistry letters
    44. BATTAGLIA G; MONN JA; SCHOEPP DD
      IN-VIVO INHIBITION OF VERATRIDINE-EVOKED RELEASE OF STRIATAL EXCITATORY AMINO-ACIDS BY THE GROUP-II METABOTROPIC GLUTAMATE-RECEPTOR AGONISTLY354740 IN RATS

      Neuroscience letters
    45. HELTON DR; TIZZANO JP; MONN JA; SCHOEPP DD; KALLMAN MJ
      LY354740 - A METABOTROPIC GLUTAMATE-RECEPTOR AGONIST WHICH AMELIORATES SYMPTOMS OF NICOTINE WITHDRAWAL IN RATS

      Neuropharmacology
    46. SCHOEPP DD; JOHNSON BG; WRIGHT RA; SALHOFF CR; MAYNE NG; WU S; COCKERHAM SL; BURNETT JP; BELEGAJE R; BLEAKMAN D; MONN JA
      LY354740 IS A POTENT AND HIGHLY SELECTIVE GROUP-II METABOTROPIC GLUTAMATE-RECEPTOR AGONIST IN CELLS EXPRESSING HUMAN GLUTAMATE RECEPTORS

      Neuropharmacology
    47. CLARKE VRJ; BALLYK BA; HOO KH; MANDELZYS A; PELLIZZARI A; BATH CP; THOMAS J; SHARPE EF; DAVIES CH; ORNSTEIN PL; SCHOEPP DD; KAMBOJ RK; COLLINGRIDGE GL; LODGE D; BLEAKMAN D
      A HIPPOCAMPAL GLUR5 KAINATE RECEPTOR REGULATING INHIBITORY SYNAPTIC TRANSMISSION

      Nature
    48. MONN JA; VALLI MJ; MASSEY SM; WRIGHT RA; SALHOFF CR; JOHNSON BG; HOWE T; ALT CA; RHODES GA; ROBEY RL; GRIFFEY KR; TIZZANO JP; KALLMAN MJ; HELTON DR; SCHOEPP DD
      DESIGN, SYNTHESIS, AND PHARMACOLOGICAL CHARACTERIZATION OF (-2-AMINOBICYCLO[3.1.0]HEXANE-2,6-DICARBOXYLIC ACID (LY354740) - A POTENT, SELECTIVE, AND ORALLY-ACTIVE GROUP-2 METABOTROPIC GLUTAMATE-RECEPTOR AGONIST POSSESSING ANTICONVULSANT AND ANXIOLYTIC PROPERTIES())

      Journal of medicinal chemistry
    49. SCHOEPP DD; SALHOFF CR; FUSON KS; SACAAN AI; TIZZANO JP; ORNSTEIN PL; MAY PC
      SELECTIVE PROTECTION AGAINST AMPA-EVOKED AND KAINATE-EVOKED NEUROTOXICITY BY ZOLE-5-YL)ETHYL]DECAHYDROISOQUINOLINE-3-CARBOXYLIC ACID (LY293558) AND ITS RACEMATE (LY215490)

      Journal of neural transmission
    50. SCHOEPP DD; SALHOFF CR; WRIGHT RA; JOHNSON BG; BURNETT JP; MAYNE NG; BELAGAJE R; WU S; MONN JA
      THE NOVEL METABOTROPIC GLUTAMATE-RECEPTOR AGONIST 2R,4R-APDC POTENTIATES STIMULATION OF PHOSPHOINOSITIDE HYDROLYSIS IN THE RAT HIPPOCAMPUS BY 3,5-DIHYDROXYPHENYLGLYCINE - EVIDENCE FOR A SYNERGISTIC INTERACTIONBETWEEN GROUP-1 AND GROUP-2 RECEPTORS

      Neuropharmacology
    51. BLEAKMAN D; BALLYK BA; SCHOEPP DD; PALMER AJ; BATH CP; SHARPE EF; WOOLLEY ML; BUFTON HR; KAMBOJ RK; TARNAWA I; LODGE D
      ACTIVITY OF 2,3-BENZODIAZEPINES AT NATIVE RAT AND RECOMBINANT HUMAN GLUTAMATE RECEPTORS IN-VITRO - STEREOSPECIFICITY AND SELECTIVITY PROFILES

      Neuropharmacology
    52. BLEAKMAN D; SCHOEPP DD; BALLYK B; BUFTON H; SHARPE EF; THOMAS K; ORNSTEIN PL; KAMBOJ RK
      PHARMACOLOGICAL DISCRIMINATION OF GLUR5 AND GLUR6 KAINATE RECEPTOR SUBTYPES BY 1(2)H-TETRAZOLE-5-YL)ETHYL]DECAHYDROISOQUINOLINE-3 CARBOXYLIC-ACID

      Molecular pharmacology
    53. SCHOEPP DD; SALHOFF CR; MONN JA
      1S,3R-ACPD STIMULATION OF PHOSPHOINOSITIDE HYDROLYSIS IN ADULT-RAT HIPPOCAMPAL SLICES IS MEDIATED BY A SYNERGISTIC INTERACTION BETWEEN GROUP-1 AND GROUP-2 MGLURS

      Journal of physiology
    54. BLEAKMAN D; SCHOEPP DD; LODGE D; ORNSTEIN PL; BUFTON H; SHARPE EF; THOMAS K; BALLYK B; KAMBOJ R
      DISCRIMINATION OF GLUR5 AND GLUR6 IONOTROPIC GLUTAMATE RECEPTOR-MEDIATED RESPONSES BY LY293558 ON SINGLE CELLS IN-VITRO

      Journal of physiology
    55. SCHOEPP DD; JOHNSON BG; MONN JA
      1S,3R)-1-AMINOCYCLOPENTANE-1,3-DICARBOXYLIC ACID-INDUCED INCREASES INCYCLIC-AMP FORMATION IN THE NEONATAL RAT HIPPOCAMPUS ARE MEDIATED BY A SYNERGISTIC INTERACTION BETWEEN PHOSPHOINOSITIDE-MGLURS AND INHIBITORY CYCLIC AMP-COUPLED MGLURS

      Journal of neurochemistry
    56. WERMUTH CG; MANN A; SCHOENFELDER A; WRIGHT RA; JOHNSON BG; BURNETT JP; MAYNE NG; SCHOEPP DD
      2-AMINO-4-(4,4-DIPHENYLBUT-1-YL)-PENTANE-1,5-DIOIC ACID - A POTENT AND SELECTIVE ANTAGONIST FOR METABOTROPIC GLUTAMATE RECEPTORS NEGATIVELYLINKED TO ADENYLATE-CYCLASE

      Journal of medicinal chemistry
    57. MONN JA; VALLI MJ; JOHNSON BG; SALHOFF CR; WRIGHT RA; HOWE T; BOND A; LODGE D; SPANGLE LA; PASCHAL JW; CAMPBELL JB; GRIFFEY K; TIZZANO JP; SCHOEPP DD
      SYNTHESIS OF THE 4 ISOMERS OF 4-AMINOPYRROLIDINE-2,4-DICARBOXYLATE - IDENTIFICATION OF A POTENT, HIGHLY SELECTIVE, AND SYSTEMICALLY-ACTIVE AGONIST FOR METABOTROPIC GLUTAMATE RECEPTORS NEGATIVELY COUPLED TO ADENYLATE-CYCLASE

      Journal of medicinal chemistry
    58. ORNSTEIN PL; ARNOLD MB; ALLEN NK; BLEISCH T; BORROMEO PS; LUGAR CW; LEANDER JD; LODGE D; SCHOEPP DD
      STRUCTURE-ACTIVITY STUDIES OF 6-(TETRAZOLYLALKYL)-SUBSTITUTED DECAHYDROISOQUINOLINE-3-CARBOXYLIC ACID AMPA RECEPTOR ANTAGONISTS .1. EFFECTSOF STEREOCHEMISTRY, CHAIN-LENGTH, AND CHAIN SUBSTITUTION

      Journal of medicinal chemistry
    59. ORNSTEIN PL; ARNOLD MB; ALLEN NK; BLEISCH T; BORROMEO PS; LUGAR CW; LEANDER JD; LODGE D; SCHOEPP DD
      STRUCTURE-ACTIVITY STUDIES OF 6-SUBSTITUTED DECAHYDROISOQUINOLINE-3-CARBOXYLIC ACID AMPA RECEPTOR ANTAGONISTS .2. EFFECTS OF DISTAL ACID BIOISOSTERIC SUBSTITUTION, ABSOLUTE STEREOCHEMICAL PREFERENCES, AND IN-VIVO ACTIVITY

      Journal of medicinal chemistry
    60. WRIGHT RA; SCHOEPP DD
      DIFFERENTIATION OF GROUP-2 AND GROUP-3 METABOTROPIC GLUTAMATE-RECEPTOR CAMP RESPONSES IN THE RAT HIPPOCAMPUS

      European journal of pharmacology
    61. DESAI MA; BURNETT JP; MAYNE NG; SCHOEPP DD
      PHARMACOLOGICAL CHARACTERIZATION OF DESENSITIZATION IN A HUMAN MGLU1-ALPHA-EXPRESSING NONNEURONAL CELL-LINE CO-TRANSFECTED WITH A GLUTAMATETRANSPORTER

      British Journal of Pharmacology
    62. LODGE D; BOND A; GOLDSWORTHY J; BAKER SR; SCHOEPP DD; MONN JA
      POTENTIATION OF AMPA-INDUCED EXCITATION BY SELECTIVE METABOTROPIC GLUTAMATE-RECEPTOR AGONISTS ON RAT SPINAL NEURONS IN-VIVO

      British Journal of Pharmacology
    63. SCHOEPP DD; TIZZANO JP; WRIGHT RA; FIX AS
      REVERSIBLE AND IRREVERSIBLE NEURONAL INJURY-INDUCED BY INTRAHIPPOCAMPAL INFUSION OF THE MGLUR AGONIST 1S,3R-ACPD IN THE RAT

      Neurodegeneration
    64. BAKER SR; GOLDSWORTHY J; HARDEN RC; SALHOFF CR; SCHOEPP DD
      ENZYMATIC RESOLUTION AND PHARMACOLOGICAL ACTIVITY OF THE ENANTIOMERS OF 3,5-DIHYDROXYPHENYLGYCINE, A METABOTROPIC GLUTAMATE-RECEPTOR AGONIST

      Bioorganic & medicinal chemistry letters
    65. SCHOEPP DD; MONN JA; TIZZANO JP
      BEHAVIORAL-EFFECTS OF COMPOUNDS ACTING AT SUBTYPES OF METABOTROPIC GLUTAMATE RECEPTORS

      Behavioural pharmacology
    66. TIZZANO JP; GRIFFEY KI; VALLI MJ; HELTON DR; KALLMAN MJ; SCHOEPP DD; MONN JA
      INTRACEREBRAL INJECTIONS OF METABOTROPIC GLUTAMATE-RECEPTOR AGONISTS CAN INDUCE OR PROTECT AGAINST LIMBIC SEIZURES IN MICE

      Behavioural pharmacology
    67. SCHOEPP DD; JOHNSON BG; SALHOFF CR; WRIGHT RA; GOLDSWORTHY JS; BAKER SR
      2ND-MESSENGER RESPONSES IN BRAIN-SLICES TO ELUCIDATE NOVEL GLUTAMATE RECEPTORS

      Journal of neuroscience methods
    68. AITKEN PG; BREESE GR; DUDEK FF; EDWARDS F; ESPANOL MT; LARKMAN PM; LIPTON P; NEWMAN GC; NOWAK TS; PANIZZON KL; RALEYSUSMAN KM; REID KH; RICE ME; SARVEY JM; SCHOEPP DD; SEGAL M; TAYLOR CP; TEYLER TJ; VOULALAS PJ
      PREPARATIVE METHODS FOR BRAIN-SLICES - A DISCUSSION

      Journal of neuroscience methods
    69. SCHOEPP DD; LODGE D; BLEAKMAN D; LEANDER JD; TIZZANO JP; WRIGHT RA; PALMER AJ; SALHOFF CR; ORNSTEIN PL
      IN-VITRO AND IN-VIVO ANTAGONISM OF AMPA RECEPTOR ACTIVATION BY ZOLE-5-YL)ETHYL]DECAHYDROISOQUINOLINE-3-CARBOXYLIC ACID

      Neuropharmacology
    70. SCHOEPP DD; JOHNSON BG; SALHOFF CR; VALLI MJ; DESAI MA; BURNETT JP; MAYNE NG; MONN JA
      SELECTIVE-INHIBITION OF FORSKOLIN-STIMULATED CYCLIC-AMP FORMATION IN RAT HIPPOCAMPUS BY A NOVEL MGLUR AGONIST, 2R,4R-4-AMINOPYRROLIDINE-2,4-DICARBOXYLATE

      Neuropharmacology
    71. TIZZANO JP; GRIFFEY KI; SCHOEPP DD
      INDUCTION OR PROTECTION OF LIMBIC SEIZURES IN MICE BY MGLUR SUBTYPE-SELECTIVE AGONISTS

      Neuropharmacology
    72. DESAI MA; VALLI MJ; MONN JA; SCHOEPP DD
      1-BCP, A MEMORY-ENHANCING AGENT, SELECTIVELY POTENTIATES AMPA-INDUCED[H-3] NOREPINEPHRINE RELEASE IN RAT HIPPOCAMPAL SLICES

      Neuropharmacology
    73. DESAI MA; BURNETT JP; MAYNE NG; SCHOEPP DD
      CLONING AND EXPRESSION OF A HUMAN METABOTROPIC GLUTAMATE-RECEPTOR 1-ALPHA - ENHANCED COUPLING ON COTRANSFECTION WITH A GLUTAMATE TRANSPORTER

      Molecular pharmacology
    74. DESAI MA; BURNETT JP; ORNSTEIN PL; SCHOEPP DD
      CYCLOTHIAZIDE ACTS AT A SITE ON THE ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLE PROPIONIC-ACID RECEPTOR COMPLEX THAT DOES NOT RECOGNIZE COMPETITIVE OR NONCOMPETITIVE AMPA RECEPTOR ANTAGONISTS

      The Journal of pharmacology and experimental therapeutics
    75. SCHOEPP DD; JOHNSON BG; DESAI MA; MAYNE N; BURNETT JP
      PHARMACOLOGICAL PROPERTIES OF CLONED HUMAN METABOTROPIC GLUTAMATE RECEPTORS

      Journal of neurochemistry
    76. DESAI MA; BURNETT JP; MAYNE NG; SCHOEPP DD
      PROPERTIES OF A CLONED HUMAN METABOTROPIC GLUTAMATE-RECEPTOR COEXPRESSED IN A MAMMALIAN-CELL LINE WITH A GLUTAMATE TRANSPORTER

      Journal of neurochemistry
    77. MONN JA; VALLI MJ; JOHNSON BG; SALHOFF CR; WRIGHT RA; SCHOEPP DD
      2R,4R-4-AMINOPYRROLIDINE-2,4-DICARBOXYLATE (4-APDC) A HIGHLY SELECTIVE AGONIST FOR METABOTROPIC GLUTAMATE RECEPTORS (MGLURS) NEGATIVELY COUPLED TO ADENYLATE-CYCLASE

      Journal of neurochemistry
    78. ORNSTEIN PL; ARNOLD MB; ALLEN NK; LEANDER JD; TIZZANO JP; LODGE D; SCHOEPP DD
      H-TETRAZOL-5-YL)DECAHYDROISOQUINOLINE-3-CARBOXYLIC ACID, A NOVEL, COMPETITIVE, SYSTEMICALLY ACTIVE NMDA AND AMPA RECEPTOR ANTAGONIST

      Journal of medicinal chemistry
    79. MITCH CH; BYMASTER FP; CALLIGARO DO; QUIMBY SJ; SCHOEPP DD; WONG DT; SHANNON HE
      MUSCARINIC ANTAGONIST ACTIVITY OF (5-ALKOXY-OXAZOL-2-YL)-1,2,5,6-TETRAHYDROPYRIDINES

      Bioorganic & medicinal chemistry letters
    80. SCHOEPP DD; LUNN WHW; SALHOFF CR; MCDONALD JW
      THE NMDA RECEPTOR AGONIST DL-(TETRAZOL-5-YL)GLYCINE IS A HIGHLY POTENT EXCITOTOXIN

      European journal of pharmacology. Environmental toxicology and pharmacology section
    81. SCHOEPP DD; SACAAN AI
      METABOTROPIC GLUTAMATE RECEPTORS AND NEURONAL DEGENERATIVE DISORDERS

      Neurobiology of aging
    82. SCHOEPP DD
      NOVEL FUNCTIONS FOR SUBTYPES OF METABOTROPIC GLUTAMATE RECEPTORS

      Neurochemistry international
    83. BOWES MP; SCHOEPP DD; ZIVIN JA
      THE AMPA GLUTAMATE ANTAGONIST LY293558 IMPROVES OUTCOME FOLLOWING REVERSIBLE SPINAL-CORD ISCHEMIA IN RABBITS

      Neurology
    84. WATTS SW; COX DA; JOHNSON BG; SCHOEPP DD; COHEN ML
      CONTRACTILE SEROTONIN-2A RECEPTOR SIGNAL-TRANSDUCTION IN GUINEA-PIG TRACHEA - IMPORTANCE OF PROTEIN-KINASE-C AND EXTRACELLULAR AND INTRACELLULAR CALCIUM BUT NOT PHOSPHOINOSITIDE HYDROLYSIS

      The Journal of pharmacology and experimental therapeutics
    85. BYMASTER FP; WONG DT; MITCH CH; WARD JS; CALLIGARO DO; SCHOEPP DD; SHANNON HE; SHEARDOWN MJ; OLESEN PH; SUZDAK PD; SWEDBERG MDB; SAUERBERG P
      NEUROCHEMICAL EFFECTS OF THE M(1) MUSCARINIC AGONIST XANOMELINE (LY246708 NNC11-0232)/

      The Journal of pharmacology and experimental therapeutics
    86. WRIGHT RA; MCDONALD JW; SCHOEPP DD
      DISTRIBUTION AND ONTOGENY OF 1S,3R-1-AMINOCYCLOPENTANE-1,3-DICARBOXYLIC ACID-SENSITIVE AND QUISQUALATE-INSENSITIVE [H-3] GLUTAMATE BINDING-SITES IN THE RAT-BRAIN

      Journal of neurochemistry
    87. SCHOEPP DD; GOLDSWORTHY J; JOHNSON BG; SALHOFF CR; BAKER SR
      3,5-DIHYDROXYPHENYLGLYCINE IS A HIGHLY SELECTIVE AGONIST FOR PHOSPHOINOSITIDE-LINKED METABOTROPIC GLUTAMATE RECEPTORS IN THE RAT HIPPOCAMPUS

      Journal of neurochemistry
    88. DESAI MA; BURNETT JP; SCHOEPP DD
      CYCLOTHIAZIDE SELECTIVELY POTENTIATES AMPA-INDUCED AND KAINATE-INDUCED [H-3] NOREPINEPHRINE RELEASE FROM RAT HIPPOCAMPAL SLICES

      Journal of neurochemistry
    89. WATTS SW; COHEN ML; MOONEY PQ; JOHNSON BG; SCHOEPP DD; BAEZ M
      DISRUPTION OF POTENTIAL ALPHA-HELIX IN THE G-LOOP OF THE GUINEA-PIG 5-HYDROXYTRYPTAMINE(2) RECEPTOR DOES NOT PREVENT RECEPTOR COUPLING TO PHOSPHOINOSITIDE HYDROLYSIS

      Journal of neurochemistry
    90. KAMBOJ RK; SCHOEPP DD; NUTT S; SHEKTER L; KORCZAK B; TRUE RA; RAMPERSAD V; ZIMMERMAN DM; WOSNICK MA
      MOLECULAR-CLONING, EXPRESSION, AND PHARMACOLOGICAL CHARACTERIZATION OF HUMEAA1, A HUMAN KAINATE RECEPTOR SUBUNIT

      Journal of neurochemistry
    91. ZIMMERMAN DM; GIDDA JS; CANTRELL BE; SCHOEPP DD; JOHNSON BG; LEANDER JD
      DISCOVERY OF A POTENT, PERIPHERALLY SELECTIVE TRANS-3,4-DIMETHYL-4-(3-HYDROXYPHENYL)PIPERIDINE OPIOID ANTAGONIST FOR THE TREATMENT OF GASTROINTESTINAL MOTILITY DISORDERS

      Journal of medicinal chemistry
    92. EVANS DC; JACOBS J; JOHNSON BG; CANTRELL BE; ROTHMAN RB; SCHOEPP DD; ZIMMERMAN DM; LEANDER JD; GIDDA JS
      LY246736 - A SELECTIVE ANTAGONIST FOR PERIPHERAL MU-OPIOID RECEPTORS

      Gastroenterology
    93. ORNSTEIN PL; ARNOLD MB; AUGENSTEIN NK; DEETER JB; LEANDER JD; LODGE D; CALLIGARO DO; SCHOEPP DD
      UNUSUAL STEREOCHEMICAL PREFERENCES OF DECAHYDROISOQUINOLINE-3-CARBOXYLIC ACID COMPETITIVE NMDA ANTAGONISTS

      Bioorganic & medicinal chemistry letters
    94. TIZZANO JP; GRIFFEY KI; JOHNSON JA; FIX AS; HELTON DR; SCHOEPP DD
      INTRACEREBRAL 1S,3R-1-AMINOCYCLOPENTANE-1,3-DICARBOXYLIC ACID (1S,3R-ACPD) PRODUCES LIMBIC SEIZURES THAT ARE NOT BLOCKED BY IONOTROPIC GLUTAMATE-RECEPTOR ANTAGONISTS

      Neuroscience letters
    95. MCDONALD JW; FIX AS; TIZZANO JP; SCHOEPP DD
      SEIZURES AND BRAIN INJURY IN NEONATAL RATS INDUCED BY 1S,3R-ACPD, A METABOTROPIC GLUTAMATE-RECEPTOR AGONIST

      The Journal of neuroscience
    96. FIX AS; SCHOEPP DD; OLNEY JW; VESTRE WA; GRIFFEY KI; JOHNSON JA; TIZZANO JP
      NEONATAL EXPOSURE TO D,L-2-AMINO-3-PHOSPHONOPROPIONATE (D,L-AP3) PRODUCES LESIONS IN THE EYE AND OPTIC-NERVE OF ADULT-RATS

      Developmental brain research
    97. SCHOEPP DD; JOHNSON BG
      METABOTROPIC GLUTAMATE, RECEPTOR MODULATION OF CAMP ACCUMULATION IN THE NEONATAL RAT HIPPOCAMPUS

      Neuropharmacology
    98. SCHOEPP DD; JOHNSON BG
      L-ASPARATE-BETA-HYDROXAMATE DISCRIMINATES MULTIPLE METABOTROPIC GLUTAMATE RECEPTORS IN THE RAT HIPPOCAMPUS

      Journal of neurochemistry
    99. SACAAN AI; SCHOEPP DD
      PERTUSSIS TOXIN POTENTIATES SEIZURES AND NEURONAL DAMAGE-INDUCED BY INTRAHIPPOCAMPAL INJECTION OF 1S,3R-1-AMINOCYCLOPENTANE-1,3-DICARBOXYLIC ACID

      Journal of neurochemistry
    100. SCHOEPP DD; ORNSTEIN PL; LEANDER JD; LODGE D
      DISCOVERY AND CHARACTERIZATION OF A NOVEL AMPA RECEPTOR ANTAGONIST, LY215490 - IN-VIVO PHARMACOLOGY

      Journal of neurochemistry


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 04/06/20 alle ore 10:56:58